TXG
10x Genomics, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$62.65
−0.90%Margins
Gross margin
70.0%
EBITDA margin
4.5%
EBIT margin
-14.3%
Net margin
-12.2%
FCF margin
19.7%
-9.1%
Return on equity
-7.3%
Return on assets
-9.8%
Return on invested capital
0.60x
Asset turnover
$127.1M
Cash from operations
$4.24
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026